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Immunization Strategies for Health Care Practices and 
Providers
Disease
20th Century
Annual Morbidity†
2017
Reported Cases † †
Percent 
Decrease
Diphtheria 21,053 0 100%
Measles 530,217 122 > 99%
Mumps 162,344 5,629 97%
Pertussis 200,752 15,808 >92%
Polio (paralytic) 16,316 0 100%
Rubella 47,745 9 > 99%
Congenital Rubella Syndrome 152 2 99%
Tetanus 580 32 95%
Haemophilus influenzae 20,000 22 > 99%
Total 999,159 24,493 97%
Vaccine Adverse Events Not available ~30,000 Not available
Comparison of 20th Century Annual Morbidity and Current Morbidity: 
Vaccine-Preventable Diseases
† JAMA. 2007;298(18):2155-2163
† †CDC. National Notifiable Diseases Surveillance System, Week 52, 2017 Weekly Tables of Infectious Disease Data. Atlanta, GA. CDC Division of Health Informatics and Surveillance, 
2018. Available at: www.cdc.gov/nndss/infectious -tables.html .  Accessed on January 4, 2018. 
*Haemophilus influenzae type b (Hib) < 5 years of age. An additional 11 cases of Hib are estimated to have occurred among the 237 notifications of Hib (< 5 years of age) with 
unknown serotype.
State/Area Combined Series*
4:3:1:3:3:1:4
United States 70.4%
Estimated Vaccination Coverage among Children Aged 19–
35 Months, NIS 2017
Data at https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/data-reports/7-series/dashboard/2017.html
*The combined (4:3:1:3:3:1:4) vaccine series includes ≥4 doses of DTaP, ≥3 doses of poliovirus vaccine, 
≥1 dose of measles-containing vaccine, full series of Hib vaccine (≥3 or ≥4 doses, depending on product 
type), ≥3 doses of HepB, ≥1 dose of varicella vaccine, and ≥4 doses of PCV
Estimated Vaccination Coverage among Adolescents 
Aged 13–17 Years, NIS-Teen, 2017
MMWR Weekly / August 25, 2017 / 66(33);874–882, and https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/index.html
Vaccine United States
≥1 Tdap 88.7%
≥1 HPV (M and F) 65.5%
UTD HPV (M and F) 48.6%
≥1 MenACWY 85.1%
https://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2018.htm
Adult Immunization Coverage, Selected Vaccines by Age and 
Increased-risk Status, 2013-2015, United States
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Data Source:  2015 NHIS, Surveillance of Vaccination Coverage Among Adult Populations — United States, 2015  MMWR Surveillance Summaries / May 5, 
2017 / 66(11);1–28, 2017 Behavioral Risk Factor Surveillance System
, 
Strategies Overview
Many available strategies
Some targeted to public and/or non-health 
care settings
 School immunization requirements
 Women Infant and Children (WIC) services
 Home visits
Match strategy to the problem and 
population
Today’s focus on health care settings
Immunization Quality Improvement for Providers (IQIP)
IQIP is designed by CDC and implemented by CDC’s 61 state 
and local immunization program awardees.
IQIP promotes and supports implementation of provider-level 
strategies designed to increase on-time vaccination among 
children and adolescents
On-time vaccination provides maximum protection against 
vaccine-preventable diseases for children and adolescents by 
ensuring they are getting the vaccines they need when they 
need them 
IQIP uses a 12-month technical assistance process to support 
VFC providers in applying quality improvement strategies to 
increase on-time vaccination
IQIP Promotes On-Time Vaccination 
Schedule the next vaccination visit before the patient leaves 
the office
Leverage immunization information system (IIS) functionality 
to improve immunization practice
Give a strong vaccine recommendation (including effective 
responses to vaccine hesitancy)
The immunization program awardees may choose to promote 
a fourth, custom strategy to address local priorities
IQIP Promotes Three (Sometime Four) Strategies
Site visit
2-month check-in
6-month check-in
 12-month follow-up 
IQIP Timeline
Observe the provider’s vaccination workflow
Review vaccination coverage and set 12-month coverage goals
Select appropriate quality improvement strategies
Provide technical assistance to support strategy 
implementation
Create a Strategy Implementation Plan with action items that 
are tailored to best meet the provider’s needs
IQIP Site Visit
Review progress made on the action items in the Strategy 
Implementation Plan
Provide technical assistance for each strategy as needed
Update the Strategy Implementation Plan with new or revised 
action items for each strategy selected
IQIP Check-Ins (2-Month and 6-Month)
Review progress made on the action items in the Strategy 
Implementation Plan
Review year-over-year changes in vaccination coverage and 
compare to the coverage goals set 12 months earlier
Provide technical assistance for each strategy as needed
Update the Strategy Implementation Plan with new or revised 
action items for each strategy selected
IQIP Follow-Up (12-Month)
Help ensure that more child and adolescent patients get the 
vaccines they need when they need them
Save time and money by reducing the need for catch-up 
appointments and follow-up for patients who are not 
vaccinated on time
Assist in meeting childhood and adolescent HEDIS measures
Benefits of IQIP for Providers
Strategies for High Immunization Levels
 Recordkeeping
 Immunization Information Systems (IIS)
 Recommendations and reinforcement
 Schedule next immunization visit before patient leaves 
the office
 Reminder and recall to patients
 Reminder and recall to providers
 Reduction of missed opportunities
 Reduction of barriers to immunization
Records
Available for inspection
Easy to interpret
Accurate, up-to-date, and complete
 reflect current patient population
 Reflect all vaccines given
Immunization Information Systems (IIS)
Single data source for 
all providers
Reliable immunization 
history
Produce records for patient use
Increase vaccination rates
http://www.cdc.gov/vaccines/programs/iis/index.html
Recommendations and Reinforcement
Recommend the vaccine 
 powerful motivator
 patients likely to follow recommendation of the provider
Reinforce the need to return 
 verbal 
 written
 link to calendar event
Reminders and Recall to Patients
 Reminder—notification that
immunizations are due soon
 Recall—notification that 
immunizations are past due
 Content of message and 
technique of delivery vary
 Reminders and recall 
have been found to be 
effective
https://www.whyimmunize.org/product/reminder-postcards-baby-bilingual/
Reminders and Recall to Providers
Communication to healthcare providers that a patient’s 
immunizations are due soon or past due
Examples 
 computer-generated list
 stamped note in the chart
 “Immunization Due” clip on chart
 electronic reminder in an electronic medical record 
Missed Opportunity
A healthcare encounter in which a person is eligible to receive 
vaccination but is not vaccinated completely
Reasons for Missed Opportunities
 Lack of simultaneous administration
 Unaware child (or adult) needs additional vaccines
 Invalid contraindications
 Inappropriate clinic policies
 Reimbursement deficiencies 
Strategies for Reducing Missed 
Opportunities
Standing orders
Provider education with feedback
Schedule the next immunization visit before 
the patient leaves the office
Provider reminder and recall systems
Reduction of Barriers to Immunization
Physical barriers clinic hours
 waiting time
 distance
 cost
Psychological barriers 
 unpleasant experience
 vaccine safety concerns 
Costs of Implementing Strategies
Intervention Strategy Median Intervention Group
Size
Median cost per person per 
year
Median cost per vaccinated 
person (US$)
Home visits 575 56 786
Client/family incentive, 
reducing costs
774 209 399
Vac in schools, child care 5,840 22 29
Vac in WIC settings 4,967 16 66
Client reminder/recall 654 2.13 15
Community based strategies in
combination
429 54 15
Provider 
reminders/assessment/fdback
2,705 4 111
Standing Orders 11,813 6 29
Healthcare system strategies 
in combination
20,000 4 12
Am J Prev Med 2016;50(6):797-808
Provider Resources
 Conversations with parents:
 https://www.cdc.gov/vaccines/parents/vaccine-decision/index.html
 Vaccines for Children Program
 https://www.cdc.gov/vaccines/programs/vfc/index.html
 The Guide to Community Preventive Services
 https://www.thecommunityguide.org/
 National Vaccine Advisory Committee. Standards for child and adolescent 
immunization practices. Pediatrics 2003;112:958-63.
 National Vaccine Advisory Committee. Recommendations from the 
National Vaccine Advisory Committee: Standards for Adult Immunization 
Practice. Public Health Reports 2014;129:115-123.
 https://journals.sagepub.com/doi/pdf/10.1177/003335491412900203
